E4orf1 Enhances Glucose Uptake Independent of Proximal Insulin Signaling

Autor: Vijay Hegde, Nikhil V. Dhurandhar, Olga Dubuisson, Ha-Na Na
Jazyk: angličtina
Rok vydání: 2016
Předmět:
Male
0301 basic medicine
Physiology
medicine.medical_treatment
Glucose uptake
lcsh:Medicine
Biochemistry
Fats
Mice
Endocrinology
0302 clinical medicine
Cell Signaling
Medicine and Health Sciences
Insulin
Small interfering RNAs
Pyrophosphatases
lcsh:Science
2. Zero hunger
Glucose tolerance test
Multidisciplinary
biology
medicine.diagnostic_test
Organic Compounds
Monosaccharides
Flow Cytometry
Lipids
Insulin oscillation
Nucleic acids
Chemistry
Infectious Diseases
Adipose Tissue
Physical Sciences
Anatomy
Rosiglitazone
Research Article
Signal Transduction
medicine.drug
medicine.medical_specialty
Infectious Disease Control
Immunoblotting
Carbohydrates
030209 endocrinology & metabolism
Carbohydrate metabolism
Transfection
Glucose Signaling
03 medical and health sciences
Insulin resistance
Internal medicine
Genetics
medicine
Animals
Non-coding RNA
Diabetic Endocrinology
Endocrine Physiology
Phosphoric Diester Hydrolases
Insulin Signaling
Organic Chemistry
lcsh:R
Chemical Compounds
Biology and Life Sciences
Cell Biology
Glucose Tolerance Test
medicine.disease
Hormones
Gene regulation
Mice
Inbred C57BL

Insulin receptor
Glucose
Biological Tissue
030104 developmental biology
biology.protein
RNA
lcsh:Q
Gene expression
Insulin Resistance
Adenovirus E4 Proteins
Zdroj: PLoS ONE, Vol 11, Iss 8, p e0161275 (2016)
PLoS ONE
ISSN: 1932-6203
Popis: Impaired proximal insulin signaling is often present in diabetes. Hence, approaches to enhance glucose disposal independent of proximal insulin signaling are desirable. Evidence indicates that Adenovirus-derived E4orf1 protein may offer such an approach. This study determined if E4orf1 improves insulin sensitivity and downregulates proximal insulin signaling in vivo and enhances cellular glucose uptake independent of proximal insulin signaling in vitro. High fat fed mice were injected with a retrovirus plasmid expressing E4orf1, or a null vector. E4orf1 significantly improved insulin sensitivity in response to a glucose load. Yet, their proximal insulin signaling in fat depots was impaired, as indicated by reduced tyrosine phosphorylation of insulin receptor (IR), and significantly increased abundance of ectonucleotide pyrophosphatase/phosphodiesterase-1 (ENPP1). In 3T3-L1 pre-adipocytes E4orf1 expression impaired proximal insulin signaling. Whereas, treatment with rosiglitazone reduced ENPP1 abundance. Unaffected by IR-KD (insulin receptor knockdown) with siRNA, E4orf1 significantly up-regulated distal insulin signaling pathway and enhanced cellular glucose uptake. In vivo, E4orf1 impairs proximal insulin signaling in fat depots yet improves glycemic control. This is probably explained by the ability of E4orf1 to promote cellular glucose uptake independent of proximal insulin signaling. E4orf1 may provide a therapeutic template to enhance glucose disposal in the presence of impaired proximal insulin signaling.
Databáze: OpenAIRE